Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. - Wikidata - awgldk - TriplyDB

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.

http://www.wikidata.org/entity/Q37188588

about

Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction Obesity and cancer--mechanisms underlying tumour progression and recurrence Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.Fibrosis and adipose tissue dysfunction.Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality.Obesity and melanoma: could fat be fueling malignancy?The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy.Contribution of Adipose Tissue to Development of Cancer.Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARγ agonist treatment.Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.

P2860

Q33827740-25E5DB2F-2EB6-4B4F-848A-4687FAD32A90 Q34425077-DC2EA269-0D4C-4C3C-9DCE-22A475EB116E Q36557469-A3A4B522-F0FF-40A8-A85D-BDC964003C2D Q37227722-FC847538-10A7-45E4-8661-8EC1E66DB6F8 Q37595806-56D30764-047D-4FA9-AEF1-A7EDA4EDE63A Q37668555-80684671-D34C-473A-BCA0-CB7DB7D3CAEE Q38286500-7BF584C7-1BA8-46CF-8D64-E517F6B703DB Q38754906-137002E4-77A1-4695-B9CD-ABE7028502D9 Q39356609-DE9E302A-A96C-4F3E-A73D-B1372CDD7738 Q47217961-A3934111-A3BF-4C6B-865D-18989683DCD5 Q49164235-5067278E-4FD9-4E42-A6A8-E4ADC1125F78 Q49367260-2F39802C-2F28-418D-9271-1353D9D133D9 Q51279076-4743405B-C37A-4153-A821-B83ED50F41D5

P2860

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.

http://www.wikidata.org/entity/Q37188588

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@en

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@nl

type

label

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@en

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@nl

prefLabel

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@en

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@nl

P1433

Q37188588-5853CA03-E143-4DB6-B060-6CD4E4309ED2

P1476

Q37188588-D75B5843-48F7-4B50-843D-C733DE1A4FCD

P2093

Q37188588-3AAFEA47-BA77-4916-A62F-96E501986DAA

Q37188588-61E71BC6-4F54-42D2-BE7F-496759AACDEA

Q37188588-BD873C03-9A40-4C43-9EE7-1E81B384A9DE

P2860

Q37188588-04586303-2C2D-42B1-AF67-37D1375F46B2

Q37188588-184DE60F-7149-41DD-A762-92820E4640B3

Q37188588-1928A6F6-ADCA-419D-80E8-605302585C52

Q37188588-2400BB51-0B42-4455-8212-D4348FB71963

Q37188588-25A47903-462D-402A-8EAB-C912CE4E240D

Q37188588-25E28C61-C49E-4254-9CCC-57104B08B3C3

Q37188588-28F44383-CBBB-4CAD-B5BF-FA4D96116C9D

Q37188588-2F6ACCF4-1F13-42D2-8286-9B935FEC33F1

Q37188588-2FB7B8E9-4D09-421F-AA24-2EE52BB613BC

Q37188588-36CECC7E-33C3-4ACF-89EC-A27DF67A675A

P304

Q37188588-32D46FCF-71E5-4CEA-A703-1C2EE1A92AE0

P31

Q37188588-7A693F10-B497-4247-B938-58CE45079D99

P356

Q37188588-01F188DE-13D4-4906-AAE1-486232F453A9

P433

Q37188588-7723D015-6FA0-47D0-BC30-7E828A7F7736

P478

Q37188588-BE6CEEA9-29BA-4598-8FB7-244D5013CCB3

P577

Q37188588-F926DD60-E1D6-4817-911F-214CBDD90518

P5875

Q37188588-A35ED15E-1391-48EE-A644-1710B6EEE616

P698

Q37188588-D430FA2E-8A89-4599-93FC-DE79BB716F29

P932

Q37188588-252A7857-86C7-4FCB-A521-1D048D1BFFED

P356

P1433

EMBO Molecular Medicine

P1476

Inhibition of endotrophin, a c ...... platin sensitivity to tumours.

@en

P2093

Jiyoung Park

http://www.w3.org/2001/XMLSchema#string

Philipp E Scherer

http://www.w3.org/2001/XMLSchema#string

Thomas S Morley

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

Fat and beyond: the diverse biology of PPARgamma

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.

Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.

Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

Leptin receptor signaling supports cancer cell metabolism through suppression of mitochondrial respiration in vivo.

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.

P304

935-948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201202006

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236581474

http://www.w3.org/2001/XMLSchema#string

P698

23629957

http://www.w3.org/2001/XMLSchema#string

P932

3779453

http://www.w3.org/2001/XMLSchema#string